Medtronic's $798 Million Trading Day Lands 90th in Market Activity

On May 20, 2025, Medtronic (MDT) experienced a trading volume of $798 million, ranking 90th in the day's stock market activity. The stock closed with a 0.69% decrease.

Wall Street analysts have given Medtronic a consensus rating of Moderate Buy, with seven Buy and seven Hold recommendations. This rating reflects a balanced view of the company's potential, with analysts advising caution due to the stock's recent volatility.

Jim Cramer, a prominent financial commentator, recently discussed Medtronic on his show, noting the company's strong position in the medical device sector. However, he advised investors to "wait and see" due to the stock's inconsistency. Cramer's comments come as the market continues to rebound from the post-Liberation Day meltdown in early April, with tech stocks leading the way.

Looking ahead to Medtronic's upcoming earnings report, analysts are projecting earnings per share of $1.58 on revenues of $8.82 billion for the quarter. This report will be closely watched by investors, as it will provide insights into the company's performance and future prospects.

Needham analysts have maintained a Hold rating on Medtronic, citing the company's strong position in the medical technology sector. However, they also note that the stock's valuation may be a concern for some investors, with a forward P/E ratio of 14.82.

Medtronic's global expansion in the Cardiovascular business is expected to support its growth in the coming quarters. The company's steady expansion in this sector is a positive sign for investors, as it indicates that Medtronic is well-positioned to capitalize on growing demand for medical technology services.